Parameters | DVT or PE group (n = 9) | Control group (n = 525) | P value | |
Female gender | 7(77.78) | 476(90.67) | 0.1291 | |
Age ≥ 65 yr | 8(88.89) | 383(72.95) | 0.2844 | |
Hospital stay over 2 wks | 3(33.33) | 88(16.76) | 0.1899 | |
Revision Sugery | 4(44.44) | 51(9.71) | 0.0007 | |
BMI ≥ 25 (kg/m2) | 1(11.11) | 317(60.38) | 0.0028 | |
Laboratory findings | Hematocrit < 38% | 6(66.67) | 250(47.62) | 0.2567 |
Platelet count < 150 × 103 | 3(33.33) | 52(9.90) | 0.0219 | |
Serum creatinine > 1.2 (mg/dl) | 2(22.22) | 94(17.90) | 0.7380 | |
ICU stay | 3(33.33) | 15(2.86) | <0.0001 | |
Use of compression stockings | 6(66.67) | 360(68.57) | 0.9029 | |
Administration of prophylactic anticoagulation | 8(88.89) | 516(98.29) | 0.0392 | |
Prophylactic anticoagulation (Enoxaparin/Fondaparinux) | 6(66.67) | 235(44.76) | 0.1904 | |
Comorbidities | Diabetes | 2(22.22) | 102(19.43) | 0.8338 |
Hypertension | 5(55.56) | 320(60.95) | 0.7422 | |
Coronary artery disease | 0(0.00) | 50(9.52) | 0.3308 | |
Cerebrovascular disease | 0(0.00) | 19(3.62) | 0.5611 | |
Chronic renal failure | 0(0.00) | 11(2.10) | 0.6608 | |
Chronic obstructive pulmonary diseases | 0(0.00) | 8(1.52) | 0.7090 | |
Malignancies | 1(11.11) | 30(5.71) | 0.4924 | |
Hyperlipidemia | 0(0.00) | 9(1.71) | 0.6920 | |
Personal history of venous thromboembolism | 1(11.11) | 0(0.00) | <0.0001 | |
Local complication | 1(11.11) | 22(4.19) | 0.3106 |